| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harvard Bioscience, Inc. (HBIO) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 17 sells. HBIO is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.80M | $16.41M | - | |
| CEO | 180.0K | $1.06M | - | |
| Dir | 58.7K | $344.4K | - | |
| Dir | 48.6K | $285.0K | - | |
| CFO | 47.5K | $278.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2015 | Duchemin Jeffrey | Chief Executive Officer | Buy | 2,000 | $4.41 | $8,820.00 | +1.3% | |
| Sep 1, 2015 | Kennedy John F | Director | Buy | 2,000 | $4.33 | $8,660.00 | +1.1% | |
| Jul 17, 2015 | Green David | Director | Sell | 17,103 | $5.26 | $89,957.75 | -1.2% | |
| Jul 14, 2015 | Green David | Director | Sell | 51,597 | $5.28 | $272,391.48 | -3.3% | |
| Apr 23, 2015 | Green David | Director | Sell | 118,500 | $6.03 | $714,555.00 | -18.3% | |
| Apr 22, 2015 | Green David | Director | Sell | 123,997 | $6.23 | $772,337.01 | -5.6% | |
| Apr 17, 2015 | Green David | Director | Sell | 42,503 | $6.55 | $278,602.77 | -1.8% | |
| Apr 14, 2015 | Green David | Director | Sell | 80,168 | $6.61 | $529,693.72 | -3.1% | |
| Feb 9, 2015 | Green David | Director | Sell | 48,712 | $5.25 | $255,738.00 | -5.2% |